Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-26-028653

SrVP/CFO/Prin Fin & Acct Ofcr acquired 10,095 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr 2026-03-12 Grant or award +10,095 43,528 D
Derivatives
Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr 2026-03-12 Grant or award · Stock Options (Right to Buy) +40,380 40,380 D
Loading xslF345X05/tm268953-1_4seq1.xml…